» Articles » PMID: 26868660

Management of Obesity

Overview
Journal Lancet
Publisher Elsevier
Specialty General Medicine
Date 2016 Feb 13
PMID 26868660
Citations 365
Authors
Affiliations
Soon will be listed here.
Abstract

A modern approach to obesity acknowledges the multifactorial determinants of weight gain and the health benefits to be derived from weight loss. Foundational to any weight loss effort is lifestyle change, diet, and increased physical activity. The approach should be a high quality diet to which patients will adhere accompanied by an exercise prescription describing frequency, intensity, type, and time with a minimum of 150 min moderate weekly activity. For patients who struggle with weight loss and who would receive health benefit from weight loss, management of medications that are contributing to weight gain and use of approved medications for chronic weight management along with lifestyle changes are appropriate. Medications approved in the USA or European Union are orlistat, naltrexone/bupropion, and liraglutide; in the USA, lorcaserin and phentermine/topiramate are also available. Surgical management (gastric banding, sleeve gastrectomy, and Roux-en Y gastric bypass) can produce remarkable health improvement and reduce mortality for patients with severe obesity.

Citing Articles

Effects of semaglutide in patients with chronic ankle instability: evidence from a prospective cohort.

Zhang J, Wang C, Wang J, Gu W, Wang H, Zhu H J Orthop Surg Res. 2025; 20(1):243.

PMID: 40050929 PMC: 11884071. DOI: 10.1186/s13018-025-05664-9.


Deciphering the anti-obesity mechanisms of pharmabiotic probiotics through advanced multiomics analysis.

Kim Y, Choi T, Jo S, Song W, Kim T, Kim M iScience. 2025; 28(2):111890.

PMID: 40017507 PMC: 11867264. DOI: 10.1016/j.isci.2025.111890.


Impact of In-Person and Mobile Exercise Coaching on Psychosocial Factors Affecting Exercise Adherence in Inactive Women With Obesity: 20-Week Randomized Controlled Trial.

Gjestvang C, Kalhovde J, Mauseth Tangen E, Clemm H, Haakstad L J Med Internet Res. 2025; 27:e68462.

PMID: 39999434 PMC: 11897673. DOI: 10.2196/68462.


Effect of semaglutide with obesity or overweight individuals without diabetes: an Umbrella review of systematic reviews.

Hu X, Wang Y, Yang K, Li X Endocrine. 2025; .

PMID: 39955702 DOI: 10.1007/s12020-025-04179-x.


Association of oral health status with overweight and obesity in older adults aged ≥ 65 years- evidence from Chinese communities.

Wu K, Yin W, Liang X, Yang Z BMC Public Health. 2025; 25(1):605.

PMID: 39948557 PMC: 11827303. DOI: 10.1186/s12889-025-21546-5.